ArticleCancer immunology, immunotherapy : CII2024

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Ravit Geva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.